Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04465552 · ClinicalTrials.gov registry record
Arrhythmic Manifestations and Management in Hospitalized COVID-19 Patients
A clinical trial, sponsored by Kansas City Heart Rhythm Research Foundation.
- Completed
- Registry status
- 666
- Enrollment target
NCT04465552: Completed study, sponsored by Kansas City Heart Rhythm Research Foundation.
NCT04465552 is a clinical trial that has completed, run by Kansas City Heart Rhythm Research Foundation. The registered enrollment target is 666 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04465552 has completed, sponsored by Kansas City Heart Rhythm Research Foundation.
- COMPLETED
- Registry status
- 666 participants
- Enrollment target
Study Summary
Although arrhythmias appear to be common in COVID-19 patients, arrhythmia mechanisms and characteristics, predisposing factors, incidence of sudden cardiac death and predictors, therapeutic strategies employed as well as long term outcomes are not well understood. Hence, we seek to develop a multicenter registry aimed to characterize arrhythmic manifestations, employed treatment strategies and long-term outcomes among hospitalized COVID-19 patients in the US.
Primary Outcome
To better characterize arrhythmic manifestations, employed treatment strategies and long- term outcomes in hospitalized COVID-19 patients in the US through a multicenter retrospective chart review.
Interventions
- OTHER Patients received standard of care treatment during hospitalization
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 666 participants |
| Start Date | 2020-07-10 |
| Est. Completion | 2021-01-24 |
What the finished NCT04465552 record still lists
NCT04465552 is an observational study that tracks outcomes without assigning an intervention. The registered 666 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which Patients received standard of care treatment during hospitalization is the first listed.
NCT04465552 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04465552 about?
NCT04465552 is a clinical study titled "Arrhythmic Manifestations and Management in Hospitalized COVID-19 Patients". Although arrhythmias appear to be common in COVID-19 patients, arrhythmia mechanisms and characteristics, predisposing factors, incidence of sudden cardiac death and predictors, therapeutic strategies employed as well as long term outcomes are not well understood. Hence, we seek to develop a multice...
What is the current status of trial NCT04465552?
This trial is currently completed. The enrollment target is 666 participants. The study started on 2020-07-10. Estimated completion is 2021-01-24.
What interventions are being tested in trial NCT04465552?
The interventions under investigation include: Patients received standard of care treatment during hospitalization (OTHER).
Who is sponsoring clinical trial NCT04465552?
This trial is sponsored by Kansas City Heart Rhythm Research Foundation, which has 22 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06328647 · 666 participants · NA
Quantra Point-of-Care Hemostasis Monitoring
- NCT06981078 · 666 participants · Phase 2
A Study to Assess the Efficacy and Safety of Verekitug in Participants With COPD
- NCT04064060 · 665 participants · Phase 3
A Study to Evaluate Long-term Safety in Participants Who Have Participated in Other Luspatercept (ACE-536) Clinical Trials
- NCT04155034 · 668 participants · Phase 3
S1827 (MAVERICK) Testing Whether the Use of Brain Scans Alone Instead of Brain Scans Plus Preventive Brain Radiation Affects Lifespan in Patients With Small Cell Lung Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI